Blog grid

26 Mar

AI-Generated Control Arms in Clinical Trials: Evidence, Opportunities, and Strategic Considerations

Clinical trials are undergoing structural change. As therapies become more targeted and patient populations more fragmented, the traditional...
20 Mar

What It Takes to Lead at the Top: Jill DeSimone on Purpose, Trust, and the...

In every industry, there are executives who build impressive careers. And then there are leaders whose careers become...
03 Mar

FDA Project Optimus: The “Right Dose” in Oncology Drug Development

Oncology drug development is undergoing a fundamental methodological transformation. With the launch of Project Optimus in 2021, the...
26 Feb

Who is Arc Nouvel: Dr. Vivian Li on Strategy, Risk, and Value in Clinical Development

Across the drug development lifecycle, including pre-IND readiness, early clinical transitions, manufacturing evolution, and regulatory engagement, biotech and...
26 Feb

Who is Arc Nouvel: Dr. Robert Charnas on Regulatory Strategy, Patient-Focused Development, and the Discipline...

Arc Nouvel is a boutique consulting firm that supports pharmaceutical, biotechnology, and investment clients with end-to-end clinical development...
24 Feb

Who Is Arc Nouvel? A Conversation with Dr. Gavin Liu on Cell Therapy CMC Strategy...

Arc Nouvel works with biotechnology and pharmaceutical companies at inflection points, pre-IND preparation, early clinical transitions, manufacturing evolution,...

Contact us Now

Follow Us